How pregnancy at early age protects against breast cancer

Trends in Molecular Medicine

Volumn 20, Issue 3, 2014, Pages 143-153

  Meier Abt, Fabienne ^a,b   Bentires Alj, Mohamed ^a  

^a FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Breast development; Hormone receptors; Mammary stem progenitor cells; Pregnancy; TGF signaling; Wnt signaling

Indexed keywords

BREAST DEVELOPMENT; HORMONE RECEPTORS; MAMMARY STEM/PROGENITOR CELLS; PREGNANCY; TGFΒ SIGNALING; WNT SIGNALING;

AGE FACTORS; ANIMALS; BREAST NEOPLASMS; CELL DIFFERENTIATION; CELL PROLIFERATION; EPITHELIAL CELLS; FEMALE; HUMANS; MAMMARY GLANDS, ANIMAL; MAMMARY GLANDS, HUMAN; MICE; PARITY; PREGNANCY; STEM CELLS; TRANSFORMING GROWTH FACTOR BETA; WNT SIGNALING PATHWAY;

EID: 84894498165     PISSN: 14714914     EISSN: 1471499X     Source Type: Journal    
DOI: 10.1016/j.molmed.2013.11.002     Document Type: Review

References (108)

1. Albrektsen G., et al. Breast cancer risk by age at birth, time since birth and time intervals between births: exploring interaction effects. Br. J. Cancer 2005, 92:167-175.
2. MacMahon B., et al. Age at first birth and breast cancer risk. Bull. World Health Organ. 1970, 43:209-221.
3. Medina D. Mammary developmental fate and breast cancer risk. Endocr. Relat. Cancer 2005, 12:483-495.
4. Rajkumar L., et al. Hormone-induced protection of mammary tumorigenesis in genetically engineered mouse models. Breast Cancer Res. 2007, 9:R12.
5. Britt K., et al. Pregnancy and the risk of breast cancer. Endocr. Relat. Cancer 2007, 14:907-933.
6. Russo I.H., Russo J. Pregnancy-induced changes in breast cancer risk. J. Mammary Gland Biol. Neoplasia 2011, 16:221-233.
7. Visvader J.E. Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis. Genes Dev. 2009, 23:2563-2577.
8. Brisken C., Duss S. Stem cells and the stem cell niche in the breast: an integrated hormonal and developmental perspective. Stem Cell Rev. 2007, 3:147-156.
9. Brisken C., O'Malley B. Hormone action in the mammary gland. Cold Spring Harb. Perspect. Biol. 2010, 2:a003178.
10. Neville M.C., et al. Hormonal regulation of mammary differentiation and milk secretion. J. Mammary Gland Biol. Neoplasia 2002, 7:49-66.
11. Daniel C.W., et al. Direct action of 17β-estradiol on mouse mammary ducts analyzed by sustained release implants and steroid autoradiography. Cancer Res. 1987, 47:6052-6057.
12. Kleinberg D.L., et al. IGF-I: an essential factor in terminal end bud formation and ductal morphogenesis. J. Mammary Gland Biol. Neoplasia 2000, 5:7-17.
13. Sternlicht M.D. Key stages in mammary gland development: the cues that regulate ductal branching morphogenesis. Breast Cancer Res. 2006, 8:201.
14. Soyal S., et al. Progesterone's role in mammary gland development and tumorigenesis as disclosed by experimental mouse genetics. Breast Cancer Res. 2002, 4:191-196.
15. Conneely O.M., et al. Progesterone-dependent regulation of female reproductive activity by two distinct progesterone receptor isoforms. Steroids 2003, 68:771-778.
16. Brisken C., et al. A paracrine role for the epithelial progesterone receptor in mammary gland development. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:5076-5081.
17. Humphreys R.C., et al. Mammary gland development is mediated by both stromal and epithelial progesterone receptors. Mol. Endocrinol. 1997, 11:801-811.
18. Brisken C., et al. Essential function of Wnt-4 in mammary gland development downstream of progesterone signaling. Genes Dev. 2000, 14:650-654.
19. Mulac-Jericevic B., et al. Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:9744-9749.
20. Fata J.E., et al. The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development. Cell 2000, 103:41-50.
21. Bradbury J.M., et al. Wnt-4 expression induces a pregnancy-like growth pattern in reconstituted mammary glands in virgin mice. Dev. Biol. 1995, 170:553-563.
22. Fernandez-Valdivia R., et al. The RANKL signaling axis is sufficient to elicit ductal side-branching and alveologenesis in the mammary gland of the virgin mouse. Dev. Biol. 2009, 328:127-139.
23. Brisken C., et al. Prolactin controls mammary gland development via direct and indirect mechanisms. Dev. Biol. 1999, 210:96-106.
24. Chen C.C., et al. Autocrine prolactin induced by the Pten-Akt pathway is required for lactation initiation and provides a direct link between the Akt and Stat5 pathways. Genes Dev. 2012, 26:2154-2168.
25. Wagner K.U., et al. Impaired alveologenesis and maintenance of secretory mammary epithelial cells in Jak2 conditional knockout mice. Mol. Cell. Biol. 2004, 24:5510-5520.
26. Brisken C., et al. IGF-2 is a mediator of prolactin-induced morphogenesis in the breast. Dev. Cell 2002, 3:877-887.
27. Hovey R.C., et al. Local insulin-like growth factor-II mediates prolactin-induced mammary gland development. Mol. Endocrinol. 2003, 17:460-471.
28. Watson C.J., Kreuzaler P.A. Remodeling mechanisms of the mammary gland during involution. Int. J. Dev. Biol. 2011, 55:757-762.
29. O'Brien J., et al. Macrophages are crucial for epithelial cell death and adipocyte repopulation during mammary gland involution. Development 2012, 139:269-275.
30. McNally S., Martin F. Molecular regulators of pubertal mammary gland development. Ann. Med. 2011, 43:212-234.
31. Roarty K., Serra R. Wnt5a is required for proper mammary gland development and TGF-β-mediated inhibition of ductal growth. Development 2007, 134:3929-3939.
32. Fleisch M.C., et al. The pleiotropic roles of transforming growth factor β in homeostasis and carcinogenesis of endocrine organs. Endocr. Relat. Cancer 2006, 13:379-400.
33. Bruno R.D., Smith G.H. Functional characterization of stem cell activity in the mouse mammary gland. Stem Cell Rev. 2011, 7:238-247.
34. Shackleton M., et al. Generation of a functional mammary gland from a single stem cell. Nature 2006, 439:84-88.
35. Sleeman K.E., et al. Dissociation of estrogen receptor expression and in vivo stem cell activity in the mammary gland. J. Cell Biol. 2007, 176:19-26.
36. Stingl J., et al. Purification and unique properties of mammary epithelial stem cells. Nature 2006, 439:993-997.
37. van Amerongen R., et al. Developmental stage and time dictate the fate of Wnt/β-catenin-responsive stem cells in the mammary gland. Cell Stem Cell 2012, 11:387-400.
38. Van Keymeulen A., et al. Distinct stem cells contribute to mammary gland development and maintenance. Nature 2011, 479:189-193.
39. Smalley M.J., et al. Isolation of mouse mammary epithelial subpopulations: a comparison of leading methods. J. Mammary Gland Biol. Neoplasia 2012, 17:91-97.
40. Pond A.C., et al. Fibroblast growth factor receptor signaling is essential for normal mammary gland development and stem cell function. Stem Cells 2013, 31:178-189.
41. Joshi P.A., et al. Progesterone induces adult mammary stem cell expansion. Nature 2010, 465:803-807.
42. Ciarloni L., et al. Amphiregulin is an essential mediator of estrogen receptor α function in mammary gland development. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:5455-5460.
43. Li Y., et al. Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:15853-15858.
44. Liu B.Y., et al. The transforming activity of Wnt effectors correlates with their ability to induce the accumulation of mammary progenitor cells. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:4158-4163.
45. Woodward W.A., et al. WNT/β-catenin mediates radiation resistance of mouse mammary progenitor cells. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:618-623.
46. Korkaya H., et al. Regulation of mammary stem/progenitor cells by PTEN/Akt/β-catenin signaling. PLoS Biol. 2009, 7:e1000121.
47. Roarty K., Rosen J.M. Wnt and mammary stem cells: hormones cannot fly wingless. Curr. Opin. Pharmacol. 2010, 10:643-649.
48. Dickson B.C., et al. High-level JAG1 mRNA and protein predict poor outcome in breast cancer. Mod. Pathol. 2007, 20:685-693.
49. Zardawi S.J., et al. High Notch1 protein expression is an early event in breast cancer development and is associated with the HER-2 molecular subtype. Histopathology 2010, 56:286-296.
50. Parr C., et al. The possible correlation of Notch-1 and Notch-2 with clinical outcome and tumour clinicopathological parameters in human breast cancer. Int. J. Mol. Med. 2004, 14:779-786.
51. O'Neill C.F., et al. Notch2 signaling induces apoptosis and inhibits human MDA-MB-231 xenograft growth. Am. J. Pathol. 2007, 171:1023-1036.
52. Kim H.A., et al. Notch1 counteracts WNT/β-catenin signaling through chromatin modification in colorectal cancer. J. Clin. Invest. 2012, 122:3248-3259.
53. Florena A.M., et al. Associations between Notch-2, Akt-1 and HER2/neu expression in invasive human breast cancer: a tissue microarray immunophenotypic analysis on 98 patients. Pathobiology 2007, 74:317-322.
54. Hu C., et al. Overexpression of activated murine Notch1 and Notch3 in transgenic mice blocks mammary gland development and induces mammary tumors. Am. J. Pathol. 2006, 168:973-990.
55. Simmons M.J., et al. NOTCH1 inhibition in vivo results in mammary tumor regression and reduced mammary tumorsphere-forming activity in vitro. Breast Cancer Res. 2012, 14:R126.
56. Han J., et al. Characterization and comparison of protein complexes initiated by the intracellular domain of individual Notch paralogs. Biochem. Biophys. Res. Commun. 2011, 407:479-485.
57. Dunphy K.A., et al. The role of activin in mammary gland development and oncogenesis. J. Mammary Gland Biol. Neoplasia 2011, 16:117-126.
58. Li H., Liu J.P. Mechanisms of action of TGF-β in cancer: evidence for Smad3 as a repressor of the hTERT gene. Ann. N. Y. Acad. Sci. 2007, 1114:56-68.
59. Bierie B., et al. TGF-β promotes cell death and suppresses lactation during the second stage of mammary involution. J. Cell. Physiol. 2009, 219:57-68.
60. Novitskiy S.V., et al. TGF-β receptor II loss promotes mammary carcinoma progression by Th17 dependent mechanisms. Cancer Discov. 2011, 1:430-441.
61. Muraoka-Cook R.S., et al. Dual role of transforming growth factor β in mammary tumorigenesis and metastatic progression. Clin. Cancer Res. 2005, 11:937s-943s.
62. Schedin P., et al. Mammary ECM composition and function are altered by reproductive state. Mol. Carcinog. 2004, 41:207-220.
63. Thordarson G., et al. Refractoriness to mammary tumorigenesis in parous rats: is it caused by persistent changes in the hormonal environment or permanent biochemical alterations in the mammary epithelia?. Carcinogenesis 1995, 16:2847-2853.
64. Bridges R.S., Byrnes E.M. Reproductive experience reduces circulating 17β-estradiol and prolactin levels during proestrus and alters estrogen sensitivity in female rats. Endocrinology 2006, 147:2575-2582.
65. Eliassen A.H., et al. Reproductive factors and family history of breast cancer in relation to plasma prolactin levels in premenopausal and postmenopausal women. Int. J. Cancer 2007, 120:1536-1541.
66. Rose D.P., et al. Rat mammary carcinoma regressions during suppression of serum growth hormone and prolactin. Anticancer Res. 1983, 3:323-325.
67. Swanson S.M., Unterman T.G. The growth hormone-deficient Spontaneous Dwarf rat is resistant to chemically induced mammary carcinogenesis. Carcinogenesis 2002, 23:977-982.
68. Harvey P.W. Hypothesis: prolactin is tumorigenic to human breast: dispelling the myth that prolactin-induced mammary tumors are rodent-specific. J. Appl. Toxicol. 2012, 32:1-9.
69. Thordarson G., et al. Insulin-like growth factor (IGF)-I obliterates the pregnancy-associated protection against mammary carcinogenesis in rats: evidence that IGF-I enhances cancer progression through estrogen receptor-α activation via the mitogen-activated protein kinase pathway. Breast Cancer Res. 2004, 6:R423-R436.
70. Maller O., et al. Collagen architecture in pregnancy-induced protection from breast cancer. J. Cell Sci. 2013, 126:4108-4110.
71. Russo J., et al. Differentiation of the mammary gland and susceptibility to carcinogenesis. Breast Cancer Res. Treat. 1982, 2:5-73.
72. Blakely C.M., et al. Hormone-induced protection against mammary tumorigenesis is conserved in multiple rat strains and identifies a core gene expression signature induced by pregnancy. Cancer Res. 2006, 66:6421-6431.
73. Russo J., et al. Full-term pregnancy induces a specific genomic signature in the human breast. Cancer Epidemiol. Biomarkers Prev. 2008, 17:51-66.
74. Guzman R.C., et al. Hormonal prevention of breast cancer: mimicking the protective effect of pregnancy. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:2520-2525.
75. Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118964 women with breast cancer from 117 epidemiological studies. Lancet Oncol. 2012, 13:1141-1151. Collaborative Group on Hormonal Factors in Breast Cancer.
76. Schneider R., et al. Factors influencing canine mammary cancer development and postsurgical survival. J. Natl. Cancer Inst. 1969, 43:1249-1261.
77. Shoker B.S., et al. Oestrogen receptor expression in the normal and pre-cancerous breast. J. Pathol. 1999, 188:237-244.
78. Barr F.E., et al. Estrogen receptor expression in atypical hyperplasia: lack of association with breast cancer. Cancer Prev. Res. (Phila.) 2011, 4:435-444.
79. Taylor D., et al. Progesterone and estrogen receptors in pregnant and premenopausal non-pregnant normal human breast. Breast Cancer Res. Treat. 2009, 118:161-168.
80. Asztalos S., et al. Gene expression patterns in the human breast after pregnancy. Cancer Prev. Res. (Phila.) 2010, 3:301-311.
81. Sivaraman L., et al. Hormone-induced refractoriness to mammary carcinogenesis in Wistar-Furth rats. Carcinogenesis 1998, 19:1573-1581.
82. Wagner K.U., et al. An adjunct mammary epithelial cell population in parous females: its role in functional adaptation and tissue renewal. Development 2002, 129:1377-1386.
83. Boulanger C.A., et al. Parity-induced mouse mammary epithelial cells are pluripotent, self-renewing and sensitive to TGF-β1 expression. Oncogene 2005, 24:552-560.
84. Lindvall C., et al. Wnt signaling, stem cells, and the cellular origin of breast cancer. Stem Cell Rev. 2007, 3:157-168.
85. Wagner K.U., Smith G.H. Pregnancy and stem cell behavior. J. Mammary Gland Biol. Neoplasia 2005, 10:25-36.
86. Siwko S.K., et al. Evidence that an early pregnancy causes a persistent decrease in the number of functional mammary epithelial stem cells - implications for pregnancy-induced protection against breast cancer. Stem Cells 2008, 26:3205-3209.
87. Britt K.L., et al. Pregnancy in the mature adult mouse does not alter the proportion of mammary epithelial stem/progenitor cells. Breast Cancer Res. 2009, 11:R20.
88. Meier-Abt F., et al. Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium. Breast Cancer Res. 2013, 15:R36.
89. + cell population with progenitor characteristics. Cell Stem Cell 2013, 13:117-130.
90. Milne R.L., et al. Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res. Treat. 2010, 119:221-232.
91. Cullinane C.A., et al. Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers. Int. J. Cancer 2005, 117:988-991.
92. Anastas J.N., Moon R.T. WNT signalling pathways as therapeutic targets in cancer. Nat. Rev. Cancer 2013, 13:11-26.
93. Hallett R.M., et al. Small molecule antagonists of the Wnt/β-catenin signaling pathway target breast tumor-initiating cells in a Her2/Neu mouse model of breast cancer. PLoS ONE 2012, 7:e33976.
94. Schedin P. Pregnancy-associated breast cancer and metastasis. Nat. Rev. Cancer 2006, 6:281-291.
95. Ursin G., et al. Reproductive factors and risk of breast carcinoma in a study of white and African-American women. Cancer 2004, 101:353-362.
96. Faupel-Badger J.M., et al. Postpartum remodeling, lactation, and breast cancer risk: summary of a National Cancer Institute-sponsored workshop. J. Natl. Cancer Inst. 2013, 105:166-174.
97. Ma H., et al. Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies. Breast Cancer Res. 2006, 8:R43.
98. Yang X.R., et al. Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J. Natl. Cancer Inst. 2011, 103:250-263.
99. Turkoz F.P., et al. Association between common risk factors and molecular subtypes in breast cancer patients. Breast 2013, 22:344-350.
100. Shinde S.S., et al. Higher parity and shorter breastfeeding duration: association with triple-negative phenotype of breast cancer. Cancer 2010, 116:4933-4943.
101. Angers S., Moon R.T. Proximal events in Wnt signal transduction. Nat. Rev. Mol. Cell Biol. 2009, 10:468-477.
102. Hoppler S., Kavanagh C.L. Wnt signalling: variety at the core. J. Cell Sci. 2007, 120:385-393.
103. Lindvall C., et al. The Wnt signaling receptor Lrp5 is required for mammary ductal stem cell activity and Wnt1-induced tumorigenesis. J. Biol. Chem. 2006, 281:35081-35087.
104. Lindvall C., et al. The Wnt co-receptor Lrp6 is required for normal mouse mammary gland development. PLoS ONE 2009, 4:e5813.
105. Zeng Y.A., Nusse R. Wnt proteins are self-renewal factors for mammary stem cells and promote their long-term expansion in culture. Cell Stem Cell 2010, 6:568-577.
106. Borggrefe T., Oswald F. The Notch signaling pathway: transcriptional regulation at Notch target genes. Cell. Mol. Life Sci. 2009, 66:1631-1646.
107. Bouras T., et al. Notch signaling regulates mammary stem cell function and luminal cell-fate commitment. Cell Stem Cell 2008, 3:429-441.
108. Raouf A., et al. Transcriptome analysis of the normal human mammary cell commitment and differentiation process. Cell Stem Cell 2008, 3:109-118.